Anzeige
Meldung des Tages: Gold bei 5.250 USD – Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!

Xoma News

Aktie
WKN:  A2ATUH ISIN:  US98419J2069 US-Symbol:  XOMA Branche:  Biotechnologie Land:  USA
26,07 $
-0,83 $
-3,09%
22,804 € 19:06:47 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
30,67%
KGV
-22,46
Dividende
0,53 EUR
Dividendenrendite
2,38%
Index-Zuordnung
-

Xoma News

22.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA PR Newswire
15.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA PR Newswire
08.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA PR Newswire
01.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA PR Newswire
24.09.25 - PR Newswire
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics PR Newswire
05.08.25 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc. PR Newswire
14.07.25 - PR Newswire
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction PR Newswire
16.02.24 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Kinnate Biopharma Inc. has obtained a Fair Price in its transaction with XOMA
Shareholder Alert: Ademi LLP investigates whether Kinnate Biopharma Inc. has obtained a Fair Price in its transaction with XOMA PR Newswire
23.03.21 - PR Newswire
Viracta and XOMA Announce Multi-License Milestone and Royalty Monetization Transaction
Viracta and XOMA Announce Multi-​License Milestone and Royalty Monetization Transaction Viracta to Receive $13.5 Million Upfront Cash Payment XOMA to Receive Economics on ...
11.12.17 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating XOMA Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating XOMA Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
08.09.15 - PR Newswire
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against XOMA Corporation and Lead Plaintiff Deadline September 22, 2015
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against XOMA Corporation and Lead Plaintiff Deadline September 22, 2015 PR Newswire
20.08.15 - PR Newswire
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
03.08.15 - PR Newswire
Robbins Arroyo LLP: XOMA Corporation (XOMA) Misled Shareholders According to a Recently Filed Class Action
Robbins Arroyo LLP: XOMA Corporation (XOMA) Misled Shareholders According to a Recently Filed Class Action PR Newswire
30.07.15 - PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against XOMA Corporation
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against XOMA Corporation PR Newswire
22.07.15 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of XOMA Corporation.
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of XOMA Corporation. PR Newswire
22.11.12 - Aktiencheck
XOMA-Aktie: "outperform" - Credit Suisse
J. Kantor, Analyst der Credit Suisse, stuft die Aktie von XOMA mit dem Votum "outperform" ein. Das Kursziel werde bei 4,00 USD gesehen. (Analyse vom 21.11.2012) ...
21.11.12 - Aktiencheck
XOMA-Aktie: "outperform" - RBC Capital Markets
Adnan Butt, Michael J. Yee und Charmaine Chan, Analysten von RBC Capital Markets, bewerten die XOMA-​Aktie mit dem Rating "outperform". (Analyse vom 20.11.2012) ...
14.11.12 - Aktiencheck
XOMA-Aktie: "outperform" - Credit Suisse
Die Analysten der Credit Suisse stufen die Aktie von XOMA in einer Ersteinschätzung mit dem Votum "outperform" ein. Das Kursziel werde bei 4,00 USD gesehen. (Analyse vom ...
09.11.12 - Aktiencheck
XOMA-Aktie: "buy" - Ladenburg Thalmann
Die Analysten von Ladenburg Thalmann stufen die Aktie von XOMA mit dem Votum "buy" ein. Das Kursziel werde von 5,50 USD auf 5,00 USD reduziert. (Analyse vom 08.11.2012) ...
09.11.12 - Aktiencheck
XOMA-Aktie: Kursziel gesenkt - Roth Capital
Die Analysten von Roth Capital bewerten die Aktie von XOMA mit dem Rating "buy". Das Kursziel werde von 6,00 USD auf 5,00 USD gesenkt. (Analyse vom 08.11.2012) ...

Newssuche

Videos

newspaper
19:20 Uhr -1,56%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »